Table 5.
Treatment | Dose (mg/kg) | Weight of organs (g) |
Organ coefficient (%) |
|||
---|---|---|---|---|---|---|
Body weight (g) | Liver | Spleen | Liver | Spleen | ||
Nanocurc | 5 | 24.90 ± 0.20a | 1.40 ± 0.05b | 0.12 ± 0.01a | 5.62a | 0.48a |
Nanocurc | 10 | 26.65 ± 1.21a | 1.31 ± 0.08b | 0.15 ± 0.01b | 4.92a | 0.56b |
Free-curc | 5 | 26.53 ± 0.77a | 1.22 ± 0.02a | 0.12 ± 0.01a | 4.60a | 0.45a |
Free-curc | 10 | 25.18 ± 0.47a | 1.14 ± 0.06a | 0.11 ± 0.00a | 4.53a | 0.44a |
Control | – | 24.25 ± 1.00a | 0.97 ± 0.07a | 0.10 ± 0.00a | 4.00a | 0.41a |
Nanocurc, nanocurcumin; Free-curc, free curcumin. Similar superscripts denote no significant difference (p > 0.05) while different superscripts denote significant difference (p < 0.05).